BioNTech - leads the way with a 5% gain. COVID VACCINE STOCKS lose 1% on average.

COVID VACCINE STOCKS slide 1% on average to begin the month. Seventeen stocks fall with 10 going up.

BioNTech lead the way with a 5% gain, climbing over $72 for the first time since August. It also climbed over $17 B in market value, leapfrogging Alnylam into second spot among the COVID VACCINE STOCKS.

The poorest performer, Generex, fell over 10% to $.2040.